NCT06015607 Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon
| NCT ID | NCT06015607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Actuated Medical, Inc. |
| Condition | Polyps Colorectal |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-06-11 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-06-11 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the safety and effectiveness of the GripTract GI Endoscopic Tissue Manipulator to the current standard of care for complex polypectomies in adults. The main questions it aims to answer are: 1. How does the number and severity of Device-Attributable Adverse Events compare to the current standard of care? 2. How is the procedure time affected? 3. Is the ability to resect the tissue en bloc affected? 4. What is the user feedback on the device performance?
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for endoscopic removal of suspected adenomatous benign polyps(s) * Patients capable of giving informed consent English and lacking cognitive impairment * No medical contraindication to endoscopic mucosal resection or endoscopic submucosal dissection Exclusion Criteria: * Patients less than 21 years of age * Any contraindication to colonoscopy with due to subject's colon anatomy (i.e., structure) * History of open or laparoscopic colorectal surgery * History of Inflammatory Bowel Disease * Patients requiring multiple polyp removals
Contact & Investigator
Emre Gorgun, MD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT06015607 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Polyps Colorectal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06015607 currently recruiting?
Yes, NCT06015607 is actively recruiting participants. Contact the research team at gorgune@ccf.org for enrollment information.
Where is the NCT06015607 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT06015607 clinical trial?
NCT06015607 is sponsored by Actuated Medical, Inc.. The principal investigator is Emre Gorgun, MD at The Cleveland Clinic. The trial plans to enroll 30 participants.